The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Expected To Change Between 2026 And 2030?
The ribose-nucleic acid (rna)-based therapeutics market size has experienced substantial growth in recent years. It is anticipated to expand from $17.22 billion in 2025 to $18.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.9%. This historical growth can be linked to advancements in molecular biology research, the early success of rna-based drugs, the broadening scope of genetic disease research, increased pharmaceutical R&D investments, and an enhanced understanding of gene regulation.
The ribose-nucleic acid (rna)-based therapeutics market is anticipated to experience significant expansion over the coming years. This market is projected to reach $26.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This expected growth can be attributed to factors such as an increase in regulatory approvals for RNA therapies, a rising need for personalized medicine, an expansion of oncology-focused RNA development pipelines, growing investments in delivery technologies, and more collaborations among biotechnology firms. Prominent trends for the forecast period include the increasing development of RNA-based targeted therapies, a rising adoption of siRNA and ASO technologies, a growing focus on rare and genetic disorders, an expansion of clinical trials for RNA therapeutics, and innovations in drug delivery systems.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
What Underlying Factors Are Accelerating The Growth Of The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The anticipated rise in cancer cases is projected to fuel the expansion of the ribose-nucleic acid (RNA)-based therapeutics market in the future. Cancer is defined as a disease characterized by the uncontrolled proliferation and dissemination of abnormal cells, which can be fatal if left untreated. Factors contributing to cancer’s widespread occurrence include an aging demographic, shifts in lifestyle, increased exposure to various risks, and enhanced detection techniques. Ribonucleic acid (RNA)-based therapies present a promising approach for combating cancer, as they directly address its genetic and molecular underpinnings. As an illustration, data from August 2023 provided by the Australian Institute of Health and Welfare, an Australian government health administration, indicated that approximately 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, a number projected to climb to 185,000 by 2030. Consequently, the growing incidence of cancer is propelling the ribose-nucleic acid (RNA)-based therapeutics market.
How Is The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Structured Across Different Segments?
The ribose-nucleic acid (rna)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Which Trends Are Influencing The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Companies operating within the ribose nucleic acid (RNA)-based therapeutics market are primarily focused on developing advanced medicinal solutions, such as messenger RNA (mRNA)-based booster vaccines. This development aims to improve the effectiveness of vaccinations, tackle emerging viral strains, and increase the long-term durability of immunity provided by vaccines. An mRNA-based booster vaccine functions by using messenger RNA to direct cells to synthesize a protein, which in turn enhances the body’s immune response against a specific pathogen. For example, in June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, introduced GEMCOVAC-OM, which is India’s first mRNA booster vaccine specifically targeting the Omicron variant of COVID-19. This booster is crucial because the initial vaccines had limited effectiveness against the Omicron variant. By employing mRNA technology, GEMCOVAC-OM enhances immunity and offers improved protection against the evolving virus.
Which Major Players Dominate The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies operating in the ribose-nucleic acid (rna)-based therapeutics market are F Hoffmann La Roche AG, Eli Lilly And Company, Novo Nordisk AS, Regeneron Pharmaceuticals, Biogen Inc., BioNTech, Alnylam Pharmaceuticals, Sarepta Therapeutics, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics, Moderna Inc., CureVac NV, Silence Therapeutics plc, ProQR Therapeutics NV
Read the full ribose-nucleic acid (rna)-based therapeutics market report here:
Which Region Is Projected To Dominate The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market During The Forecast Period?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2025. The regions covered in the ribose-nucleic acid (rna)-based therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
Browse Through More Reports Similar to the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market 2026, By The Business Research Company
Dna Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Rna Sequencing Services Global Market Report
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report
Protein Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model